Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 29,600 AVIR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 29,600 | n/a |
| Jun 24, 2025 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 29,600 | n/a |
| Jun 21, 2024 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 29,600 | n/a |
| Jun 18, 2024 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 33,150 | n/a |
| Jun 21, 2023 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 33,150 | n/a |
| Jun 21, 2022 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 61,264 | n/a |
| Jun 21, 2021 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 34,025 | n/a |
| Oct 30, 2020 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 80,000 | n/a |